JULIE NANGIA to Receptors, TNF-Related Apoptosis-Inducing Ligand
This is a "connection" page, showing publications JULIE NANGIA has written about Receptors, TNF-Related Apoptosis-Inducing Ligand.
Connection Strength
0.031
-
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer. Clin Cancer Res. 2015 Jun 15; 21(12):2722-9.
Score: 0.031